Here are the S-3 shelf registrations from Whitehawk Therapeutics, Inc. (WHWK) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow WHWK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WHWK filings page.
Whitehawk Therapeutics is registering the resale of up to 22,321,887 shares of its common stock. These Shares consist of 4,330,866 outstanding shares and 17,991,021 shares issuable upon exercise of pre-funded warrants sold in a Private Placement closed May 14, 2026. The Company will receive no proceeds from resales under this prospectus and has agreed to bear registration expenses per a Registration Rights Agreement executed with the purchasers. The Private Placement raised approximately $87.5 million at a purchase price of $3.92 per share (and $3.9199 per pre-funded-warrant share), and certain holders are subject to Beneficial Ownership Limitations (4.99%, 9.99% or 19.99%, at holder election).